Grants

NIH Grants

Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cells.

Evaluation of a beta cell replacement therapy combined product that avoids the need for immunosuppression via localized induction of immune tolerance

Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing.

Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cells.

Development of a rapid and inexpensive luciferase-based high throughput screening assay to identify compounds that alter pancreatic β cell function.

Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applications.